Akt induces enhanced myocardial contractility and cell size in vivo in transgenic mice.
Condorelli G
Proc Natl Acad Sci U S A. 99(19):12333-8.
MicroRNA-133 controls cardiac hypertrophy.
Carè A
Nat Med. 2007 Apr 29;13(5):613-8.
Inhibition of class I histone deacetylase with an apicidin derivative prevents cardiac hypertrophy and failure.
Gallo P
Cardiovasc Res. 2008 Aug 12;80(3):416-24. doi: 10.1093/cvr/cvn215
Akt regulates L-type Ca2+ channel activity by modulating Cavalpha1 protein stability.
Catalucci D
J Cell Biol. 184(6):923-33. doi: 10.1083/jcb.200805063
The knockout of miR-143 and -145 alters smooth muscle cell maintenance and vascular homeostasis in mice: correlates with human disease.
Elia L
Cell Death Differ. 2009 Oct 9;16(12):1590-8. doi: 10.1038/cdd.2009.153
Reciprocal regulation of microRNA-1 and insulin-like growth factor-1 signal transduction cascade in cardiac and skeletal muscle in physiological and pathological conditions.
Elia L
Circulation. 2009 Nov 23;120(23):2377-85. doi: 10.1161/CIRCULATIONAHA.109.879429
MicroRNA control of podosome formation in vascular smooth muscle cells in vivo and in vitro.
Quintavalle M
J Cell Biol. 2010 Mar 29;189(1):13-22. doi: 10.1083/jcb.200912096
MTORC1 regulates cardiac function and myocyte survival through 4E-BP1 inhibition in mice.
Zhang D
J Clin Invest. 2010 Jul 19;120(8):2805-16. doi: 10.1172/JCI43008
Circulating miR-29a, among other up-regulated microRNAs, is the only biomarker for both hypertrophy and fibrosis in patients with hypertrophic cardiomyopathy.
Roncarati R
J Am Coll Cardiol. 2013 Oct 23;63(9):920-7. doi: 10.1016/j.jacc.2013.09.041
Genome-wide analysis of histone marks identifying an epigenetic signature of promoters and enhancers underlying cardiac hypertrophy.
Papait R
Proc Natl Acad Sci U S A. 2013 Nov 27;110(50):20164-9. doi: 10.1073/pnas.1315155110